AI transparency Archives - Pharma Marketing Network

Home Tags AI transparency

pharma-ai-bias-audit-clinical-fairness

The AI-Bias Audit: Why Pharma Marketers Must Champion Clinical Fairness

Donna Pacheco - June 8, 2026

Doctor discussing AI medical scribe technology with a concerned patient during a healthcare consultation

The AI Scribe Backlash: Why Patients Distrust Automated Healthcare

Donna Pacheco - May 22, 2026

Putting a Human Face on AI: Building Trust in Pharma’s Automated...

Donna Pacheco - February 9, 2026

State AI Laws, One Brand Story: Keeping Pharma Marketing Coherent Across...

Donna Pacheco - January 30, 2026

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Scientist analyzing biomarker data and DNA diagnostics in a modern laboratory, illustrating biomarker diagnostic marketing and precision medicine strategies in the pharmaceutical industry.

Marketing the Biomarker Before the Brand: Pharma’s New Growth Strategy

June 23, 2026

Climate-driven disease spread visualized through predictive healthcare analytics, showing emerging infectious disease risk zones and pharmaceutical marketing intelligence.

When Diseases Move North: The New Geography of Pharma Marketing

June 23, 2026

GLP-1 injection pen, medication vial, and safety warning materials illustrating overdose concerns, dosing errors, and pharmaceutical risk communication challenges.

The GLP-1 Safety Reckoning: Why Overdose Headlines Are Becoming a Marketing...

June 22, 2026